Showing results (641-650 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|April 16, 2015
Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients?Mariana Rieck, Artur F Schumacher-Schuh, Sidia M Callegari-Jacques, et al.Pharmacogenomics|October 13, 2012
Conference scene: Latin American Pharmacogenomics and Personalized Medicine ConferenceGuilherme Suarez-KurtzPharmacogenomics|October 13, 2012
HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitorsDaniel Fuerst, Sumit Parmar, Christian Schumann, et al.Pharmacogenomics|October 13, 2012
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeedingAdeniyi Olagunju, Andrew Owen, Tim R CresseyPharmacogenomics|October 13, 2012
Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancerGuoyan Liu, Da Yang, Yan Sun, et al.Pharmacogenomics|August 28, 2012
Targeted pharmacogenetic analysis of antipsychotic response in the CATIE studyQian Liu, Maidar Jamba, Calvin Patrick, et al.Pharmacogenomics|August 28, 2012
Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysisSimona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.Pharmacogenomics|September 13, 2012
Integrative systems biology approaches in asthma pharmacogenomicsAmber Dahlin, Kelan G TantisiraPharmacogenomics|September 13, 2012
The current and future state of pharmacogenomics medical education in the USATracey J Nickola, James S Green, Arthur F Harralson, et al.Pharmacogenomics|September 13, 2012
Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritisCatherine O'Doherty, Matthew Schnabl, Llewellyn Spargo, et al.Pageof 276